Teprotumumab for dysthyroid optic neuropathy: early functional and structural improvement in a retrospective case series
Ai Kozaki, Rishu Inoue, Natsuko Watanabe, Nobuyuki Sato et autres
Dysthyroid optic neuropathy (DON) is a severe, vision-threatening manifestation of thyroid eye disease. We conducted a retrospective descriptive case series of consecutive patients with DON treated with teprotumumab at a single center to evaluate functional, structural, magnetic resonance imaging (MRI)-based inflammatory, and …
jp (code pays fourni par la source)
0 citations
Endocrine Journal